Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Mar;33(3):E63-8.
doi: 10.1002/clc.20576.

Prevention of contrast-induced nephropathy: a single center randomized study

Affiliations
Randomized Controlled Trial

Prevention of contrast-induced nephropathy: a single center randomized study

Diego Castini et al. Clin Cardiol. 2010 Mar.

Abstract

Background: Contrast-induced nephropathy (CIN) is the third cause of acute deterioration of renal function in hospitalized patients.

Hypothesis: The purpose of the study was to compare the efficacy of saline infusion, saline infusion plus N-acetylcysteine (NAC), and sodium bicarbonate (SB) infusion to prevent CIN in patients undergoing coronary angiography and/or percutaneous coronary intervention.

Methods: We prospectively studied 156 patients with a baseline creatinine level > or = 1.2 mg/dL. The primary endpoint was the development of CIN, defined as an increase in serum creatinine concentration > or = 25% over the baseline value within 5 days from contrast exposure.

Results: Contrast-induced nephropathy developed in 23 patients (14.7%). Incidence of the primary endpoint was similar in the 3 groups of treatment, occurring in 7 patients (14%) in the saline infusion group, in 9 (17%) in the saline infusion plus NAC group, and in 7 (14%) in the SB infusion group.

Conclusions: Our findings suggest that neither the addition of NAC nor the administration of SB add further benefit in CIN prevention, compared to standard hydration with isotonic saline infusion.

PubMed Disclaimer

References

    1. Nash K, Hafeez A, Hou S. Hospital‐acquired renal insufficiency. Am J Kidney Dis 2002; 39: 930–936. - PubMed
    1. Marenzi G, Lauri G, Assanelli E, et al. Contrast‐induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004; 44: 1780–1785. - PubMed
    1. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002; 105: 2259–2264. - PubMed
    1. Stacul F, Adam A, Becker CR, et al. Strategies to reduce the risk of contrast‐induced nephropathy. Am J Cardiol 2006; 98: 59K–77K. - PubMed
    1. Schweiger MJ, Chambers CE, Davidson CJ, et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Cathet Cardiovasc Interven 2007; 69: 135–140. - PubMed

Publication types

MeSH terms